Inventurus Knowledge Solutions Limited’s Board of Directors has approved the retirement of Mr. Berjis Desai as Non-Executive Chairman and Non-Independent Director, effective from the conclusion of the company’s 20th Annual General Meeting (AGM) on September 21, 2026. The leadership transition follows Mr. Desai’s appointment as a Member of the National Commission for Minorities, Government of India, a role that requires his substantial presence in New Delhi. Consequently, the Board has designated Mr. Clarence Carleton King II, an Independent Director, as the new Non-Executive Chairman and Independent Director with effect from the same date. This governance update was disclosed in a filing submitted under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026.

The decision was formalized during the Board meeting held on August 5, 2026, which commenced at 07:15 P.M. IST and concluded at 08:44 P.M. IST. In a letter dated August 5, 2026, Mr. Desai expressed his unwillingness to seek re-appointment at the ensuing AGM due to the conflicting demands of his new government role. He clarified that he would continue to serve as a Director until the expiry of his term at the forthcoming AGM. The Board accepted his resignation and simultaneously approved the change in designation for Mr. King II to ensure continuity in leadership.

Leadership Transition Details

Mr. Berjis Desai, who holds an LL.M. from Cambridge and is a Solicitor & Advocate at the High Court of Bombay, has been a key figure in the company’s governance structure. His departure marks a significant shift in the boardroom dynamics. Successing him is Mr. Clarence Carleton King II (Carl), a senior healthcare executive with 40 years of diverse experience in healthcare financing and delivery. Mr. King II brings extensive expertise in managing HMOs, PPOs, and managed care plans, having led organizations with profit and loss responsibilities ranging from millions to over US$9 billion annually. He is a Certified Corporate Director by the National Association of Corporate Directors and the Indian Institute of Corporate Affairs.

Financial Context and Recent Developments

This governance update coincides with the company’s strong financial performance in Q1FY27. Inventurus Knowledge Solutions reported a consolidated net profit of ₹1,937.41 million, a 27.8% increase year-on-year. Revenue from operations grew 20.7% to ₹8,936.29 million, driven by its care enablement platform segment. The Board meeting that approved the director changes also reviewed these unaudited standalone and consolidated financial results.

Additionally, the company completed the acquisition of TruBridge, Inc., on July 9, 2026, for an enterprise value of up to US$557 million, treated as a non-adjusting subsequent event. It also acquired 100% of ARAI Solutions Private Limited on May 14, 2026, for ₹110 million. These strategic moves, alongside the leadership transition, underscore the company’s focus on scaling operations while maintaining robust corporate governance structures.

What the Numbers Show

The leadership change occurs against a backdrop of improved operating leverage, with EBITDA growing 24% to ₹2,949 million. The appointment of Mr. King II, with his deep background in healthcare financing, aligns with the company’s expansion into complex healthcare delivery models through acquisitions like TruBridge. This suggests a strategic intent to leverage specialized executive expertise to integrate large-scale acquisitions and optimize capital efficiency in the evolving healthcare technology landscape.

Inventurus Knowledge Solutions Limited will host an earnings conference call to discuss its financial performance for the first quarter of fiscal year 2026-27 (Q1 FY27). The event is scheduled for Thursday, August 6, 2026, at 8:30 AM India Standard Time (IST). This disclosure has been made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”).

The announcement was signed by Sameer S Chavan, Company Secretary and Compliance Officer of Inventurus Knowledge Solutions Limited, on July 31, 2026. The filing was submitted to both the Bombay Stock Exchange Limited and the National Stock Exchange of India Limited. The company’s scrip code on BSE is 544309, and its symbol on NSE is IKS.

Investors and analysts can participate in the conference call via dial-in numbers or a web participant link. The company has provided universal access numbers as well as international toll-free lines for participants from the USA, UK, Singapore, and Hong Kong. Registration for the Diamond Pass is also available through a dedicated link.

Conference Call Schedule

For further inquiries regarding the earnings call, investors may contact Saransh Mundra from the Investor Relations team via email at investor_relations@ikshealth.com .